» Articles » PMID: 40031980

[High Expression of Apolipoprotein C1 Promotes Proliferation and Inhibits Apoptosis of Papillary Thyroid Carcinoma Cells by Activating the JAK2/STAT3 Signaling Pathway]

Overview
Specialty General Medicine
Date 2025 Mar 3
PMID 40031980
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the expression of apolipoprotein C1 (APOC1) in papillary thyroid carcinoma (PTC) and its effects on proliferation and apoptosis of PTC cells.

Methods: The expression level of APOC1 in PTC and its impact on prognosis were analyzed using GEPIA 2 and Kaplan-Meier databases. Immunohistochemistry (IHC) and Western blotting were used to detect the expression of APOC1 in PTC and adjacent tissues and in 3 PTC cell lines and normal thyroid Nthyori 3-1 cells. In TPC-1 and BCPAP cells, the effect of Lipofectamine 2000-mediated transfection with APOC1 siRNA or an APOC1-overexpressing plasmid on cell growth and colony formation ability were examined by observing the growth curves and using colony-forming assay. The changes in cell cycle and apoptosis of the transfected cells were analyzed with flow cytometry. RT-qPCR and Western blotting were used to detect the changes in expressions of P21, P27, CDK4, cyclin D1, Bcl-2, Bax, caspase-3 and caspase-9 and the key proteins in the JAK2/STAT3 signaling pathway.

Results: APOC1 expression was significantly higher in PTC tissues and the 3 PTC cell lines than in the adjacent tissues and Nthyori 3-1 cells, respectively. In TPC-1 and BCPAP cells, APOC1 knockdown obviously reduced cell proliferative activity, increased the percentage of G0/G1 phase cells, lowered the percentages of S and G2 phase cells, promoted cell apoptosis, and downregulated mRNA and protein expression levels of CDK4, cyclin D1 and Bcl-2 and the protein levels of p-JAK2 and p-STAT3. APOC1 overexpression in the cells produced the opposite effects on cell proliferation, apoptosis, cell cycle and the mRNA and protein expressions. The application of AG490, a JAK2 inhibitor, strongly attenuated APOC1 overexpression-induced activation of the JAK2/STAT3 signaling pathway in BCPAP cells.

Conclusions: APOC1 overexpression promotes proliferation and inhibits apoptosis of PTC cells possibly by activating the JAK2/STAT3 signaling pathway and accelerating cell cycle progression.

References
1.
Jiang H, Tang J, Xue D, Chen Y, Wu T, Zhuang Q . Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling. Cancer Cell Int. 2021; 21(1):41. PMC: 7802262. DOI: 10.1186/s12935-020-01713-x. View

2.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M, Dal Maso L . Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med. 2016; 375(7):614-7. DOI: 10.1056/NEJMp1604412. View

3.
Judd L, Menheniott T, Ling H, Jackson C, Howlett M, Kalantzis A . Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. PLoS One. 2014; 9(5):e95993. PMC: 4013079. DOI: 10.1371/journal.pone.0095993. View

4.
Wang J, Zhang Y, Song H, Yin H, Jiang T, Xu Y . The circular RNA circSPARC enhances the migration and proliferation of colorectal cancer by regulating the JAK/STAT pathway. Mol Cancer. 2021; 20(1):81. PMC: 8167978. DOI: 10.1186/s12943-021-01375-x. View

5.
Yi J, Ren L, Wu J, Li W, Zheng X, Du G . Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer. Ann Transl Med. 2019; 7(16):380. PMC: 6736826. DOI: 10.21037/atm.2019.07.59. View